459 related articles for article (PubMed ID: 25225860)
21. Thromboembolic Risk of Cessation of Oral Anticoagulation Post Catheter Ablation in Patients With and Without Atrial Fibrillation Recurrence.
Rong B; Han W; Lin M; Hao L; Zhang K; Chen T; Sha R; Wang J; Wang R; Zhong J
Am J Cardiol; 2020 Dec; 137():55-62. PubMed ID: 33002462
[TBL] [Abstract][Full Text] [Related]
22. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.
Riley MP; Zado E; Hutchinson MD; Lin D; Bala R; Garcia FC; Callans DJ; Cooper JM; Verdino RJ; Dixit S; Marchlinski FE
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):591-6. PubMed ID: 24533561
[TBL] [Abstract][Full Text] [Related]
23. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP
Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822
[TBL] [Abstract][Full Text] [Related]
24. [Very long term follow-up after radiofrequency ablation for atrial fibrillation: the Geneva experience].
Tessitore E; Tran VN; Sunthorn H; Burri H; Namdar M; Shah D
Rev Med Suisse; 2015 May; 11(476):1180-4. PubMed ID: 26182636
[TBL] [Abstract][Full Text] [Related]
25. Thromboembolic events 7-11 years after catheter ablation of atrial fibrillation.
Tran VN; Tessitore E; Gentil-Baron P; Jannot AS; Sunthorn H; Burri H; Mach F; Shah D
Pacing Clin Electrophysiol; 2015 Apr; 38(4):499-506. PubMed ID: 25626468
[TBL] [Abstract][Full Text] [Related]
26. Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation.
Pothineni NVK; Amankwah N; Santangeli P; Schaller RD; Supple GE; Deo R; Nazarian S; Garcia FC; Dixit S; Callans DJ; Marchlinski FE; Frankel DS
J Cardiovasc Electrophysiol; 2021 Feb; 32(2):345-353. PubMed ID: 33382500
[TBL] [Abstract][Full Text] [Related]
27. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
[TBL] [Abstract][Full Text] [Related]
28. Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
Kanaoka K; Nishida T; Iwanaga Y; Nakai M; Tonegawa-Kuji R; Nishioka Y; Myojin T; Okada K; Noda T; Kusano K; Miyamoto Y; Saito Y; Imamura T
Eur Heart J; 2024 Feb; 45(7):522-534. PubMed ID: 38117227
[TBL] [Abstract][Full Text] [Related]
29. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Marinkovic JM; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
[TBL] [Abstract][Full Text] [Related]
30. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Left Atrial Appendage Closure and Oral Anticoagulation After Atrial Fibrillation Catheter Ablation.
Fei ZT; Yao PC; Qiu JH; Chen M; Fei YD; Li W; Zhang PP; Sun J; Wang QS; Li YG
Am J Cardiol; 2023 Oct; 204():312-319. PubMed ID: 37567023
[TBL] [Abstract][Full Text] [Related]
32. Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary?
Ha AC; Hindricks G; Birnie DH; Verma A
Curr Opin Cardiol; 2015 Jan; 30(1):1-7. PubMed ID: 25389647
[TBL] [Abstract][Full Text] [Related]
33. Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. The Loire Valley Atrial Fibrillation Project.
Philippart R; Brunet-Bernard A; Clementy N; Bourguignon T; Mirza A; Angoulvant D; Babuty D; Lip GY; Fauchier L
Thromb Haemost; 2016 May; 115(5):1056-63. PubMed ID: 26843425
[TBL] [Abstract][Full Text] [Related]
34. The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study.
Yang WY; Du X; Jiang C; He L; Fawzy AM; Wang L; Liu C; Xia SJ; Chang SS; Guo XY; Li SN; Tang RB; Liu N; Bai R; Sang CH; Jiang CX; Yu RH; Long DY; Dong JZ; Lip GYH; Ma CS
Europace; 2020 Jan; 22(1):90-99. PubMed ID: 31909431
[TBL] [Abstract][Full Text] [Related]
35. Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry.
Kornej J; Kosiuk J; Hindricks G; Arya A; Sommer P; Rolf S; Husser D; Lip GY; Bollmann A
Clin Res Cardiol; 2015 Jul; 104(7):603-10. PubMed ID: 25707763
[TBL] [Abstract][Full Text] [Related]
36. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
37. Impact of structural heart disease on the acute complication rate in atrial fibrillation ablation: results from the German Ablation Registry.
Hoffmann BA; Kuck KH; Andresen D; Spitzer SG; Hoffmann E; Schumacher B; Eckardt L; Brachmann J; Becker R; Steven D; Rostock T; Jünger C; Senges J; Willems S
J Cardiovasc Electrophysiol; 2014 Mar; 25(3):242-9. PubMed ID: 24237758
[TBL] [Abstract][Full Text] [Related]
38. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
39. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
[TBL] [Abstract][Full Text] [Related]
40. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
